Bridging the Gap with Bioelectronics

Science has entered a new era in which molecules are being used as building blocks, moving parts, and even as electronic components. Biomolecules offer great potential as component parts because nature has already done much of the work; their very shapes and chemical makeup encode a variety of exploitable functions, including binding, catalysis, pumping, and self-assembly.2 A case in point: Science magazine hailed the first molecular-scale circuits as 2001's "Breakthrough of the Year."1 Researc

Written byDeborah Fitzgerald
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Researchers in the rapidly progressing field of molecular bioelectronics are coupling biomolecules with some unlikely mates from the "non-biotic" side of town: electronic transducers. Communication between these odd partners from the biologic and nonliving worlds is effected by the passage of electrons. The potential rewards for these innovations are considerable. Bioelectronic systems could one day be employed in a wide variety of apparatuses, including biosensors, devices for driving biotransformations, biofuel cells, and perhaps even biocomputers.3-5

The biomolecular and electronic components are electrically connected via molecular electron transfer relays. The specifics of how this is accomplished vary greatly, and can involve biomolecules that are inherently capable of electron transfer, such as redox enzymes or exogenous electronic mediators, which can be attached to the electrode or a biomolecule, or can act as diffusional electron couriers. Biomolecules and electronic elements are joined using any of a variety of techniques, but the redox-active portions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies